127 related articles for article (PubMed ID: 38325833)
1. Axillary Lymphadenopathy after COVID-19 Vaccination: Follow-up for Enlarged Lymph Nodes on MR Imaging.
Kanemaru N; Yoshikawa T; Miki S; Nakao T; Nakamura Y; Fujimoto K; Abe O
Magn Reson Med Sci; 2024 Feb; ():. PubMed ID: 38325833
[TBL] [Abstract][Full Text] [Related]
2. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
[TBL] [Abstract][Full Text] [Related]
3. The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination.
Mukai K; Tsunoda H; Imai R; Numata A; Kida K; Oba K; Yagishita K; Yamauchi H; Kanomata N; Kurihara Y
Jpn J Radiol; 2023 Jun; 41(6):617-624. PubMed ID: 36626076
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
5. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M
Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025
[TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Axillary Lymph Nodes on Breast MRI Before and After COVID-19 Booster Vaccination.
Parikh R; Feigin KN; Sevilimedu V; Huayanay J; Pinker K; Horvat JV
Acad Radiol; 2024 Mar; 31(3):755-760. PubMed ID: 37037711
[TBL] [Abstract][Full Text] [Related]
10. Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Acta Radiol; 2020 Jun; 61(6):848-855. PubMed ID: 31615267
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
12. Evaluation of mediastinal lymphadenopathy by diffusion weighted MRI; correlation with histopathological results.
Abou Youssef HA; Elzorkany MA; Hussein SA; Taymour TA; Abdel Gawad MH
Adv Respir Med; 2019; 87(3):175-183. PubMed ID: 31282559
[TBL] [Abstract][Full Text] [Related]
13. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
14. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study.
Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM
Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
16. Role of diffusion-weighted MR imaging in cervical lymphadenopathy.
Abdel Razek AA; Soliman NY; Elkhamary S; Alsharaway MK; Tawfik A
Eur Radiol; 2006 Jul; 16(7):1468-77. PubMed ID: 16557366
[TBL] [Abstract][Full Text] [Related]
17. Diffusion weighted magnetic resonance imaging is a feasible method for characterizing regional lymph nodes in canine patients with head and neck disease.
Stahle JA; Larson MM; Rossmeisl JH; Dervisis N; Neelis D
Vet Radiol Ultrasound; 2019 Mar; 60(2):176-183. PubMed ID: 30418693
[TBL] [Abstract][Full Text] [Related]
18. Differentiation Between Benign and Metastatic Breast Lymph Nodes Using Apparent Diffusion Coefficients.
Fardanesh R; Thakur SB; Sevilimedu V; Horvat JV; Gullo RL; Reiner JS; Eskreis-Winkler S; Thakur N; Pinker K
Front Oncol; 2022; 12():795265. PubMed ID: 35280791
[TBL] [Abstract][Full Text] [Related]
19. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
20. Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.
Tyagi N; Riaz N; Hunt M; Wengler K; Hatzoglou V; Young R; Mechalakos J; Lee N
Med Phys; 2016 Jan; 43(1):137. PubMed ID: 26745906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
